NO823767L - Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser

Info

Publication number
NO823767L
NO823767L NO823767A NO823767A NO823767L NO 823767 L NO823767 L NO 823767L NO 823767 A NO823767 A NO 823767A NO 823767 A NO823767 A NO 823767A NO 823767 L NO823767 L NO 823767L
Authority
NO
Norway
Prior art keywords
hydrogen
compound
formula
alkyl
carbon atoms
Prior art date
Application number
NO823767A
Other languages
English (en)
Norwegian (no)
Inventor
David Brown
Rodney Brian Hargreaves
Bernard Joseph Mcloughlin
Stuart Dennett Mills
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of NO823767L publication Critical patent/NO823767L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/64—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/21—Radicals derived from sulfur analogues of carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO823767A 1981-11-12 1982-11-11 Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser NO823767L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8134175 1981-11-12

Publications (1)

Publication Number Publication Date
NO823767L true NO823767L (no) 1983-05-13

Family

ID=10525836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO823767A NO823767L (no) 1981-11-12 1982-11-11 Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser

Country Status (14)

Country Link
US (3) US4495185A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0080296A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5890567A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU563867B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1199028A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK500382A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES517332A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI823894A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR77365B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL67185A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO823767L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ202472A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT75827B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA828304B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4616014A (en) * 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
US4495185A (en) * 1981-11-12 1985-01-22 Imperial Chemical Industries, Plc 1,2,4-Triazin-3(2H) ones
CA1199027A (en) * 1981-11-12 1986-01-07 Stuart D. Mills Heterocyclic derivatives of pyridazinone, thiadiazinone, oxadiazinone and triazinone
JPS5962578A (ja) * 1982-10-04 1984-04-10 Mitsui Toatsu Chem Inc オキサジアジン誘導体およびそれを含有する医薬組成物
GB8310435D0 (en) * 1983-04-18 1983-05-25 Fujisawa Pharmaceutical Co Triazine derivatives
JPS59196874A (ja) * 1983-04-22 1984-11-08 Fujisawa Pharmaceut Co Ltd トリアジン誘導体
JPS61106574A (ja) * 1984-10-29 1986-05-24 Yoshitomi Pharmaceut Ind Ltd オキサ（またはチア）ジアジン誘導体
US4782066A (en) * 1985-04-19 1988-11-01 Uniroyal Chemical Company, Inc. Substituted oxadiazinone miticidal compositions and use
DE3631085A1 (de) * 1986-09-12 1988-03-24 Boehringer Mannheim Gmbh Heterocyclisch substituierte indolinone, verfahren zu ihrer herstellung, arzneimittel sowie zwischenprodukte
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
HU212783B (en) * 1990-12-22 1996-11-28 Egyt Gyogyszervegyeszeti Gyar Process for producing new thiobenzoyl morpholide derivatives and weight increasing agents comprising such compounds
HU209473B (en) * 1990-12-22 1994-06-28 Egyt Gyogyszervegyeszeti Gyar Process for production of fodder-additives, premixes and fodders containing n-thiobenzoil-morpholine derivatives with weight-gain increasing action
FR2671551B1 (fr) * 1991-01-15 1993-03-12 Adir Nouveaux composes de structure aryl triazinique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE4134893A1 (de) * 1991-10-23 1993-04-29 Merck Patent Gmbh Thiadiazinone
US5446163A (en) * 1992-10-02 1995-08-29 Reilly Industries, Inc. Preparation of hydrazones, dihydrothiadiazoles and triazinones
DE4239540A1 (de) * 1992-11-25 1994-05-26 Asta Medica Ag Neue heterocyclische Verbindungen mit antiasthmatischer/antiallergischer, entzündungshemmender, positiv inotroper und blutdrucksenkender Wirkung
DE4310699A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Thiadiazinone
EP3661917B1 (en) 2017-08-04 2022-05-11 Bayer Aktiengesellschaft 6-((3-trifluoromethyl)phenyl)-4,5-dihydropyridazin-3(2h)-one derivatives as pde3a and pde3b inhibitors for treating cancer
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
WO2020157189A1 (en) 2019-02-01 2020-08-06 Bayer Aktiengesellschaft 1,2,4-triazin-6(1h)-one compounds for the treatment of hyperproliferative diseases
WO2020157201A1 (en) 2019-02-01 2020-08-06 Bayer Aktiengesellschaft Oxadiazinone compounds for the treatment of hyperproliferative diseases
WO2020157188A1 (en) 2019-02-01 2020-08-06 Bayer Aktiengesellschaft Dihydrooxadiazinones for the treatment of hyperproliferative diseases
CN113348165B (zh) * 2019-02-01 2024-06-25 拜耳股份有限公司 用于治疗过度增殖性疾病的1,2,4-三嗪-3(2h)-酮化合物
CN117903077B (zh) * 2023-01-13 2024-09-03 上海超阳药业有限公司 二氢噁二嗪酮化合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3377345A (en) * 1966-09-23 1968-04-09 Dow Chemical Co Substituted 3, 4, 5, 6-tetrahydro-2h-1, 3, 4-oxadiazin-2-one compounds and method ofpreparation thereof
US3946010A (en) * 1975-04-09 1976-03-23 E. R. Squibb & Sons, Inc. 3-Phenyl-2,5-dihydro-as-triazin-6 (1H)-ones
US4097671A (en) * 1975-08-28 1978-06-27 General Electric Company Dihydrooxadiazinones and method for making
US4105848A (en) * 1976-12-27 1978-08-08 General Electric Company Process for the production of dihydrooxadiazinone compounds
DE3172252D1 (en) * 1980-11-14 1985-10-17 Ici Plc Heterocyclic compounds
US4495185A (en) * 1981-11-12 1985-01-22 Imperial Chemical Industries, Plc 1,2,4-Triazin-3(2H) ones
US4489074A (en) * 1982-11-12 1984-12-18 Imperial Chemical Industries, Plc 1,3,4-Thiadiazin-2-ones
JPH072947B2 (ja) * 1985-06-27 1995-01-18 松下電子工業株式会社 螢光体

Also Published As

Publication number Publication date
US4694005A (en) 1987-09-15
PT75827A (en) 1982-12-01
GR77365B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-09-11
JPS5890567A (ja) 1983-05-30
DK500382A (da) 1983-05-13
US4584298A (en) 1986-04-22
IL67185A0 (en) 1983-03-31
US4495185A (en) 1985-01-22
FI823894A0 (fi) 1982-11-12
ES8404339A1 (es) 1984-04-16
ZA828304B (en) 1983-09-28
FI823894L (fi) 1983-05-13
NZ202472A (en) 1985-11-08
ES517332A0 (es) 1984-04-16
FI823894A7 (fi) 1983-05-13
AU563867B2 (en) 1987-07-23
AU9038882A (en) 1983-05-19
EP0080296A1 (en) 1983-06-01
CA1199028A (en) 1986-01-07
PT75827B (en) 1985-11-12

Similar Documents

Publication Publication Date Title
NO823767L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser
US4503054A (en) 6-Aryl-1,2,4-triazin-6-ones which possess cardiotonic properties
US4489073A (en) 1,3,4-Thiadiazin-5-ones
US4489074A (en) 1,3,4-Thiadiazin-2-ones
CZ297798A3 (cs) Farmaceuticky vhodné isochinolinové deriváty a způsob jejich přípravy
JPH0641455B2 (ja) ピリダジノン誘導体
US5258397A (en) 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions
KR100559816B1 (ko) Ｎｏｓ 저해작용을 가진 방향족 아민 유도체
DK159969B (da) Pyridazinderivater, der har psykotropisk virkning, og laegemidler indeholdende dem
US3235557A (en) New oxazoline derivatives
US4493835A (en) 1,3,4-Thiadiazines
US3940406A (en) Derivatives of 1-phenoxy-3-amino-propane-2-ol and process for their production
US4109088A (en) 2-(indenyloxymethyl) morpholine derivatives
Harris et al. Synthetic plant growth regulators. The synthesis of Co-Carboxyphenyl derivatives of some five-membered heterocycles
CS216525B2 (en) Method of making the phenylpiperazine derivatives
US5059599A (en) Derivatives of 1-phenyl 1,4-dihydro 3-amino 4-oxo pyridazines, their preparation and their use in therapy
US3308024A (en) Method of tranquilization
US4873243A (en) Derivatives of 3-imino-pyridazine, process for obtaining them and pharmaceutical compositions containing them
EP0392233B1 (de) Substituierte 1.2.3.4-Oxatriazolium-5-olate, Verfahren zu ihrer Herstellung und ihre Verwendung
US5604226A (en) Pyridazinone derivatives, processes for production thereof and use thereof
US3931207A (en) Tetramic acid analogs of pulvinic acid
US5446163A (en) Preparation of hydrazones, dihydrothiadiazoles and triazinones